European Foundation
for the Improvement of
Living and Working Conditions

The tripartite EU agency providing knowledge to assist
in the development of better social, employment and
work-related policies

EU PolicyWatch

Database of national-level policy measures

Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.

Factsheet for measure FR-2023-42/3405 Updated – measures in France

Collective agreement on ecological transition and sustainable mobility in the pharmaceutical industry

Accord collectif du 17 octobre 2023 sur la transition écologique et la mobilité durable dans l’industrie pharmaceutique

Country France , applies nationwide
Time period Open ended, started on 17 October 2023
Context Green Transition
Type Bipartite collective agreements
Category Reorientation of business activities
– Change of production/Innovation
Author Frédéric Turlan (IRshare), Pascale Turlan (IRshare) and Eurofound
Measure added 12 November 2023 (updated 03 November 2025)

Background information

On 17 October 2023, the employers' organisation LEEM and the CFDT, FO, Unsa and CFTC trade unions signed a collective agreement on the ecological transition and sustainable mobility in the pharmaceutical industry, the first industry-wide agreement on this subject in France. With a view to meet the sector's decarbonisation commitments, companies must carry out a carbon assessment of their activities within 12 months, and then implement an action plan. Companies with more than 300 employees will have to set up an environmental committee responsible for 'studying the environmental impact of the company's strategic decisions or its environmental strategy'.

Content of measure

Having committed to a 50% reduction in direct CO2 emissions and a 25% reduction in indirect emissions, LEEM has proposed a collective agreement on ecological transition and sustainable mobility to the sector's social partners.

Under the terms of this agreement, the sector undertakes, in particular, to set up:

  • An environmental commission, or any other commission or working group, in companies with more than 300 employees. This committee will be responsible for studying the environmental impact of the company's strategic decisions or its environmental strategy.
  • At the same time, companies in the sector will have to examine the issue of ecological transition as part of all company negotiations.
  • A carbon audit within 12 months: companies in the sector are encouraged to carry out a situational analysis enabling them to assess the actions already taken within their organisation. The signatory parties wish to make it compulsory for companies to carry out a carbon assessment of their activities within 12 months of signing the agreement.

The agreement stipulates that LEEM will provide companies with a number of tools to help them implement ecological transition initiatives. Companies in the sector undertake to implement at least two best practice measures before the end of 2024. These measures may relate to executive remuneration, catering, responsible purchasing or transport, with the introduction of a mobility map if measures are taken on this last point.

Updates

The following updates to this measure have been made after it came into effect.

24 September 2024

The Minister of Labour and Employment extended, by order dated September 24, 2024, and published on Octobre, 8, 2024, the provisions of the agreement of October 17, 2023, on ecological transition and sustainable mobility, concluded under the IDD 176.

Use of measure

The agreement applies to 93,816 employees on permanent contract and 9,411 employees in short-term contract working the pharmaceutical industry.

Contents

  • Other topics

Target groups

Workers Businesses Citizens
Employees in standard employment
Workers in non-standard forms of employment
Sector specific set of companies
Does not apply to citizens

Actors and funding

Actors Funding
Social partners jointly
Companies
Employers organisation

Social partners

Social partners' role in designing the measure and form of involvement:

Trade unions Employers' organisations
Role Agreed (outcome) incl. social partner initiative Agreed (outcome) incl. social partner initiative
Form Not applicable Not applicable

Social partners' role in the implementation, monitoring and assessment phase:

  • Social partners jointly
  • Main level of involvement: Sectoral or branch level

Involvement

The employers' organisation LEEM has signed the agreement with four trade unions (CFDT, Force Ouvrière, UNSA and CFTC) which represented 62.94% of the votes in the last professional elections, enabling the agreement to be validated.

Views and reactions

No information.

Sectors and occupations

    • Economic area Sector (NACE level 2)
      C - Manufacturing C20 Manufacture of chemicals and chemical products

This case is not occupation-specific.

Sources

  • 22 August 2021: Loi n° 2021-1104 du 22 août 2021 portant lutte contre le dérèglement climatique et renforcement de la résilience face à ses effets (www.legifrance.gouv.fr)
  • 17 October 2023: Accord collectif sur la transition écologique et la mobilité durable dans l’industrie pharmaceutique (www.irshare.eu)
  • 06 November 2023: LEEM (2023), Le secteur pharmaceutique confirme son engagement pour la transition industrielle en signant le 1er accord de branche (www.leem.org)
  • 24 September 2024: Arrêté du 24 septembre 2024 portant extension d'un accord conclu dans le cadre de la convention collective nationale de l'industrie pharmaceutique (n° 176) (www.legifrance.gouv.fr)

Citation

Eurofound (2023), Collective agreement on ecological transition and sustainable mobility in the pharmaceutical industry, measure FR-2023-42/3405 (measures in France), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/FR-2023-42_3405.html

Share

Eurofound publications based on EU PolicyWatch

All publications are available on the EU PolicyWatch landing page .

Disclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.